We are live on ! Find out more
SRTAW

Strata Critical Medical Inc Warrants

Delisted

SRTAW was delisted on the 6th of May, 2026.

10 hedge funds and large institutions have $4.41M invested in Strata Critical Medical Inc Warrants in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.03% less ownership

Funds ownership: 9.64%9.6% (-0.03%)

9% less funds holding

Funds holding: 1110 (-1)

30% less capital invested

Capital invested by funds: $6.26M → $4.41M (-$1.85M)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
2
Calls
$368K
Puts
Net Calls
+$368K
Net Calls Change
-$346K
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$1.46M
Walleye Capital
2
Walleye Capital
New York
$1.27M +$104K +232,247 +13%
LP
3
LMR Partners
United Kingdom
$654K +$6.4K +14,300 +1%
ICM
4
Ionic Capital Management
New York
$508K
Morgan Stanley
5
Morgan Stanley
New York
$444K
CAC
6
Cowen and Company
New York
$30.4K +$21.5K +48,000 New
SCM
7
Saba Capital Management
New York
$19K
Two Sigma Investments
8
Two Sigma Investments
New York
$17.3K
HF
9
HRT Financial
New York
$14K -$3.78K -8,454 -29%
TRCT
10
Tower Research Capital (TRC)
New York
$14
DCM
11
Difesa Capital Management
New York
-$101K -219,875 Closed
AAS
12
Ameritas Advisory Services
Nebraska
-$4.08K -8,500 Closed

SRTAW Hedge Fund Activity: Q2 2023 in Review

10 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc Warrants (SRTAW) for Q2 2023, worth a combined $4.41M — down 30% from $6.26M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SRTAW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.

The largest buyer was Walleye Capital, adding an estimated $104K. The largest seller was Difesa Capital Management, exiting entirely with an estimated $101K sold.

  • 10 institutional investors held Strata Critical Medical Inc Warrants (SRTAW) as of Q2 2023, down from 11 in Q1 2023.
  • Funds reported $4.41M of Strata Critical Medical Inc Warrants stock for Q2 2023, down 30% quarter-over-quarter.
  • 1 fund opened new Strata Critical Medical Inc Warrants positions in Q2 2023 and 2 closed out, a net change of -1 holder.
  • The largest Strata Critical Medical Inc Warrants buyer in Q2 2023 was Walleye Capital, an estimated $104K added.
  • The largest Strata Critical Medical Inc Warrants seller in Q2 2023 was Difesa Capital Management, an estimated $101K sold.

Based on aggregated 13F filings for Q2 2023.